Welcome to the BioPharmaceutical Emerging Best Practices Association (BEBPA), a non-profit organization dedicated to advancing patient safety through the collaborative efforts of the biopharmaceutical scientific community. BEBPA provides an international forum for the presentation and discussion of scientific issues and challenges encountered in biopharmaceutical research and development. We host in-person and vritual conferences and workshops which focus on the exchange of emerging best practices in the biopharmaceutical field.  By fostering open discussions at these conferences, BEBPA aims to promote innovative approaches and solutions that enhance patient safety and expedite the development of effective and reliable biopharmaceutical products.

Additionally, BEBPA aims to publish white papers that address challenges faced by the biopharmaceutical community, including companies, regulators, and clinicians, during product development. These papers will identify emerging issues that benefit from early discussion and provide a variety of approaches to solving common problems. To support this process, smaller conferences will focus on these topics, leading to the publication of non-consensus white papers.

These papers are not intended to serve as formal guidance documents but rather to present diverse perspectives for scientific discussion. Because they do not prescribe a preferred approach, they can be published quickly to contribute to ongoing dialogue. By sharing potential solutions, BEBPA seeks to accelerate the development of consensus best practices within the biopharmaceutical community.